Why Biogen Stock Popped Today

What happened?On Friday morning, Biogen (NASDAQ: BIIB) released an update regarding its Biologics License Application (BLA) for aducanumab as a potential treatment for Alzheimer’s disease (AD). The drugmaker wasn’t too forthcoming with details in this update — and there was certRead MoreMarketsMarkets Feed

¡Haz clic para votar esta entrada!
(Votos: 0 Promedio: 0)

Deja un comentario